- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SIENTRA Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 293,20 | -1,84 % | Aktien New York: Dow steuert mit Rekord auf 50.000 Punkte zu | NEW YORK (dpa-AFX) - Die Jahresauftakt-Rally an den US-Börsen ist am Dienstag weitergegangen. Der Leitindex Dow Jones Industrial stieg den zweiten Handelstag in Folge auf ein Rekordhoch und steuert... ► Artikel lesen | |
| THERMO FISHER | 528,30 | -0,55 % | BofA Raises Thermo Fisher (TMO) Target as Biopharma Recovery Comes Into View | ||
| TELADOC HEALTH | 6,473 | -5,38 % | BofA Securities lowers Teladoc stock price target to $7.50 on segment uncertainties | ||
| ROKU | 94,03 | -2,99 % | Will Roku Dominate Streaming Stocks in 2026? | ||
| RESMED | 212,60 | -0,28 % | RESMED INC: Statement of CDIs on issue - RMD | ||
| ATOSSA THERAPEUTICS | 0,585 | +3,91 % | Atossa Therapeutics Inc: Atossa Therapeutics Receives FDA "Study May Proceed" Letter for (Z)-Endoxifen Investigational New Drug Application for Metastatic Breast Cancer | SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines for unmet... ► Artikel lesen | |
| HENRY SCHEIN | 67,00 | -0,33 % | Henry Schein Allows KKR To Buy Up To 19.9% Of Stake, Lifts Annual Outlook; Stock Up Over 8% | MELVILLE (dpa-AFX) - Henry Schein, Inc. (HSIC), a distributor of health care products and services, said on Tuesday that its Board has approved an amendment to the strategic partnership agreement... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| ZIMMER BIOMET | 79,66 | -1,75 % | Dividendenbekanntmachungen (30.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) APA GROUP AU000000APA1 0,275 AUD 0,1563 EUR AUTOHOME INC KYG066341028 0,3 USD 0,2548 EUR BRITISH AMERICAN TOBACCO PLC ADR US1104481072 0... ► Artikel lesen | |
| PETMED EXPRESS | 3,001 | -1,90 % | PetMed Express, Inc.: PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited | DELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the "Company" or "PetMeds"), today confirmed that it has... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc. - 8-K, Current Report | ||
| TANDEM DIABETES | 19,940 | -1,09 % | TANDEM DIABETES CARE INC - 8-K, Current Report | ||
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| QUIDELORTHO | 27,400 | -1,44 % | QuidelOrtho Corporation: QuidelOrtho Reports Third Quarter 2025 Financial Results | ? Total revenue of $700 million; excluding COVID-19 and Donor Screening, revenue grew mid-single digits, demonstrating solid underlying growth and momentum ? ... ► Artikel lesen | |
| VERU | 2,370 | +1,28 % | Veru Inc.: Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress | -- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an... ► Artikel lesen |
SIENTRA INC gehört der Branche Gesundheitswesen an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIENTRA INC finden Sie auf Wallstreet Online.